| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $19.98M | - | |
| CEO | 1.74M | $10.53M | -41,666 | |
| Other | 409.9K | $2.48M | - | |
| CFO | 409.1K | $2.47M | - | |
| Other | 339.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Raab Michael56 | President &CEO | Sale+OE | 41,668 | $5.36 | $223,198.81 | -2.5% | -31.3% | +17.2% | |
| Feb 24, 2025 | Mott David M88 | Director | Buy | 77,729 | $5.00 | $388,738.27 | +4.0% | -22.6% | +27.9% | |
| Feb 20, 2025 | Williams Laura A55 | Chief Medical Officer | Sell | 4,941 | $5.62 | $27,783.24 | -1.6% | -30.2% | +0.2% | |
| Feb 20, 2025 | Renz Justin A54 | Chief Financial Officer | Sell | 5,171 | $5.62 | $29,076.53 | -1.8% | -30.2% | +0.2% | |
| Feb 20, 2025 | Raab Michael56 | President &CEO | Sell | 22,964 | $5.62 | $129,124.28 | -2.1% | -30.2% | +0.2% | |
| Feb 20, 2025 | Grammer Elizabeth A58 | See Remarks | Sell | 4,291 | $5.62 | $24,128.29 | -2.3% | -30.2% | +0.2% | |
| Jan 31, 2025 | Raab Michael56 | President &CEO | Sale+OE | 41,666 | $5.36 | $223,354.76 | -3.6% | +2.1% | +43.5% | |
| Jan 21, 2025 | Mott David M88 | Director | Buy | 199,000 | $4.99 | $992,671.70 | +11.4% | -7.1% | +62.7% | |
| Jan 7, 2025 | Raab Michael56 | President &CEO | Sale+OE | 41,666 | $5.31 | $221,308.96 | -3.6% | -17.7% | +7.8% | |
| Dec 19, 2024 | Mott David M88 | Director | Buy | 213,300 | $4.67 | $996,580.26 | +15.0% | +14.5% | +21.1% |